Arvinas Inc (ARVN)
26.80
-0.10
(-0.37%)
USD |
NASDAQ |
Nov 04, 16:00
26.81
+0.01
(+0.04%)
After-Hours: 20:00
Arvinas Profit Margin (Quarterly): -48.05% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | -48.05% |
June 30, 2024 | -46.01% |
March 31, 2024 | -274.3% |
December 31, 2023 | |
September 30, 2023 | -185.0% |
June 30, 2023 | -122.2% |
March 31, 2023 | -252.0% |
December 31, 2022 | -219.3% |
September 30, 2022 | -199.4% |
June 30, 2022 | -207.1% |
March 31, 2022 | -239.2% |
December 31, 2021 | -159.6% |
September 30, 2021 | -503.2% |
June 30, 2021 | -914.5% |
March 31, 2021 | -745.5% |
Date | Value |
---|---|
December 31, 2020 | -657.3% |
September 30, 2020 | -405.7% |
June 30, 2020 | -438.9% |
March 31, 2020 | -348.4% |
December 31, 2019 | -428.2% |
September 30, 2019 | -58.82% |
June 30, 2019 | -427.4% |
March 31, 2019 | -358.6% |
December 31, 2018 | -467.6% |
September 30, 2018 | -396.6% |
June 30, 2018 | -231.0% |
March 31, 2018 | -101.0% |
December 31, 2017 | -183.8% |
September 30, 2017 | -383.3% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-914.5%
Minimum
Jun 2021
-46.01%
Maximum
Jun 2024
-336.5%
Average
-252.0%
Median
Mar 2023
Profit Margin (Quarterly) Benchmarks
NovaBay Pharmaceuticals Inc | -66.04% |
Palatin Technologies Inc | -2.36K% |
iBio Inc | -4.44K% |
Theriva Biologics Inc | -- |
Oragenics Inc | -- |
Profit Margin (Quarterly) Related Metrics
Return on Equity | -52.97% |
Return on Assets | -25.62% |
Return on Invested Capital | -52.90% |
Operating Margin (Quarterly) | -58.89% |
Return on Net Operating Assets | -1.28K% |